$HLTH News Article - Cue Health to Announce Second Quarter
Top 10 Most Recent News Articles
D-Wave Investors Must Decide by Dec 15 Class Suit
Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...
Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves
Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...
Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms
Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...
Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials
Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...
Continue ReadingTop 5 Most Recently Viewed Articles
Empowering Local Students: LBCC's Exciting Summer Initiative
Long Beach City College Announces Summer Learning Camps Long Beach City College (LBCC) is thrilled to introduce the Summer of Learning, a transformative series of free day camps that aim to empower local high school students and adult learners. Set to occur over eight weeks, this initiative includes engaging workshops in game design, skilled trades, and foundational...
Continue Reading
Surging Growth in Portable Otoscope Market to $550 Million
Growth of the Portable Otoscope Market The global portable otoscope market is currently valued at approximately $300 million and is expected to skyrocket to around $550 million by the year 2034. This remarkable growth is indicative of a compound annual growth rate (CAGR) of 6.5% from 2025 to 2034. Factors driving this expansion include a rising demand for mobile...
Continue Reading
August 2025 Services Sector Shows Continued Expansion Trends
Current State of Services PMI The Services PMI for August 2025 showed a growth rate of 52%, signaling that economic activity within the services sector continues to expand for the third consecutive month. The Business Activity Index recorded a robust 55%, demonstrating notable growth, and the New Orders Index also reflected strength at 56%, up from 50.3% in July....
Continue Reading
Franklin Limited Duration Income Trust Announces Monthly Payout
Franklin Limited Duration Income Trust Announces Monthly Distribution Franklin Limited Duration Income Trust [NYSE American: FTF] recently revealed its monthly distribution plan to its shareholders. The Fund will provide a distribution of $0.0615 per share, enhancing the financial outlook for its investors. Details on the Distribution Plan The monthly distribution from...
Continue Reading
Explore the Class Action Investigation for Silvaco Group, Inc.
Understanding the Class Action Investigation for Silvaco Group, Inc. As shareholder awareness grows, so does the importance of understanding potential securities class action investigations. This has come to light for Silvaco Group, Inc. (NASDAQ: SVCO), where concerns have arisen regarding possible misinformation disclosed by the company. Such developments often lead...
Continue Reading